Alternative patient identification: To ensure timely access to medical marijuana, patients who have received application approval may now use their official OMMA approval email or approval in the OMMA MedPortal as a valid form of identification at licensed dispensaries. Read more here: UPDATE: Guidance on Alternative Patient ID
The Oklahoma Medical Marijuana Authority (OMMA) exercises its regulatory authority under OAC 442:10 to protect public health by identifying and removing unsafe products through formal recalls and administrative embargoes.
In the event of an embargo or recall, corrective responsibilities are shared by OMMA and commercial licensees:
Adherence to these protocols is a mandatory, and any failure to comply in a timely manner may result in the suspension or revocation of the commercial license, or monetary penalties.
Visit the OMMA Rules & Legislation tab for additional information. For questions regarding rules or legislation, please seek legal counsel.
The Oklahoma Medical Marijuana Authority (OMMA) has issued a recall for several medical marijuana pre-roll batches processed by Sunny Roads Processing 2, LLC (PAAA-8JA2-CK1Z). The included products failed testing due to pesticide content above allowable thresholds.
The Oklahoma Medical Marijuana Authority (OMMA) has issued a mandatory recall for medical marijuana products tested by Greenleaf Labs LLC (LAAA-MP4O-T1EE) between April 2023 and July 2025. This action follows a previous emergency order establishing product safety concerns that remain unresolved by the licensee.
Improperly tested medical marijuana can pose immediate health risks. Mold and yeast levels exceeding compliance thresholds may lead to adverse reactions.
The Oklahoma Medical Marijuana Authority (OMMA) issued an embargo on Jan. 21, 2026, for products processed and/or labeled by OK Farms (PAAA-FQG6-QLJP) and RX Harvest Botanicals (PAAA-F0B4-WJQP). These facilities are not legal operators, and the license numbers were not issued by OMMA.
The products were discovered at Bud Guys LLP (DAAA-X7XP-Q2J9) dispensary in Tulsa. Because the products were not tagged in the state inventory tracking system, testing of the products cannot be confirmed.
These products are not safe for consumption. Patients who purchased them should dispose of them and/or contact a physician if they experience any adverse health effects. Patients can also report medical events via OMMA’s Health Impact Form.
The Oklahoma Medical Marijuana Authority (OMMA) issued an embargo on Dec. 11, 2025, and a recall on Dec. 23, 2025, for products derived from concentrates originating from Carter County Extracts, Inc. (PAAA-NKNM-0GP0).
The products were recalled after failing for pesticides (Myclobutanil); view the full product table below.
Patients who purchased these products should check their packaging/product label for the batch number listed in the table. If the numbers match, dispose of the product or contact the dispensary you purchased from. If a patient consumes any of the products mentioned and experiences an adverse health reaction, they should contact their physician immediately and fill out OMMA’s Health Impact Form.
Processors that received the recall notice are required to inform dispensaries that bought the recalled products. Dispensaries must notify patients who purchased the recalled products and remove the items from shelves immediately. Licensees are responsible for disposing of recalled products per OMMA rules. Commercial licensees whose harvest or production batches are being recalled are responsible for disposal costs of all waste.
Vice Capital Extraction, LLC issued a voluntary recall on Tuesday, November 25, 2025, of pre-rolls that they produced.
The recall was prompted by marijuana flower that failed microbial testing and was then combined with other marijuana flower material, thereby contaminating the product.
Additionally, Vice Capital Extraction, LLC has emailed clients about the recall and will cover the disposal costs incurred by affected licensees.
Patients who purchased these products should check their packaging/product label for the batch number listed in the table. If the numbers match, dispose of the product or contact the dispensary you purchased from. If a patient consumes any of the products mentioned and experiences an adverse health reaction, they should contact their physician immediately and fill out OMMA’s Health Impact Form.
Processors that received the recall notice are required to inform dispensaries that bought the recalled products. Dispensaries must notify patients who purchased the recalled products and remove the items from shelves immediately. Licensees are responsible for disposing of recalled products per OMMA rules. Commercial licensees whose harvest or production batches are being recalled are responsible for disposal costs of all waste.
The Oklahoma Medical Marijuana Authority (OMMA) issued an embargo on Oct. 13, 2025, and a recall on Oct. 24, 2025, for products sold by Green Delight 2 LLC (DAAA-4JYA-UHMD).
The products were recalled after failing for pesticides; view the full product table below.
Patients who purchased these products should check their packaging/product label for the batch number listed in the table. If the numbers match, dispose of the product or contact the dispensary you purchased from. If a patient consumes any of the products mentioned and experiences an adverse health reaction, they should contact their physician immediately and fill out OMMA’s Health Impact Form.
Processors that received the recall notice are required to inform dispensaries that bought the recalled products. Dispensaries must notify patients who purchased the recalled products and remove the items from shelves immediately. Licensees are responsible for disposing of recalled products per OMMA rules. Commercial licensees whose harvest or production batches are being recalled are responsible for disposal costs of all waste.
OMMA issued an embargo on Oct. 13, 2025, and a recall on Oct. 23, 2025, for products produced by Ruby Mae’s LLC (PAAA-EKRQ-5DLS).
The products were recalled for improper testing methods; view the full product table below.
Patients who purchased these products should check their packaging/product label for the batch number listed in the table. If the numbers match, dispose of the product or contact the dispensary you purchased from. If a patient consumes any of the products mentioned and experiences an adverse health reaction, they should contact their physician immediately and fill out OMMA’s Health Impact Form.
Processors that received the recall notice are required to inform dispensaries that bought the recalled products. Dispensaries must notify patients who purchased the recalled products and remove the items from shelves immediately. Licensees are responsible for disposing of recalled products per OMMA rules. Commercial licensees whose harvest or production batches are being recalled are responsible for disposal costs of all waste.
The Oklahoma Medical Marijuana Authority (OMMA) issued an embargo on Sept. 25, 2025, and a recall on Oct. 10, 2025, for products produced by Michael William Redus DBA Rocking R Cannabis (PAAA-1H79-INUS).
The Oklahoma Medical Marijuana Authority (OMMA) issued an embargo and recall on March 25, 2025, for multiple Payzos Flower & Buds, Grape Cream Cake Flower & Buds and Zour Apples Flower & Buds products due to the presence of heavy metals.
PAK Family Farm, LLC (GAAI-VYPS-KBZ2) contacted OMMA about testing concerns after producing the products. Their report led to an investigation by OMMA that revealed a similar test reporting issue by the same lab for Clever Leaf Outdoor, LLC (GAAA-VFSO-CG6V) products, prompting the embargo and recall. OMMA commends the efforts of both businesses to help swiftly remove these products from dispensary shelves. The collaboration was instrumental in protecting patient health and ensuring compliance.
OMMA issued an embargo on June 7, 2024, and a Recall Notice on June 10, 2024. The listed products produced by Graves Farm Organics LLC (PAAA-EYKG-PCTX) failed re-testing for pesticides during an investigation.
OMMA issued a recall notice on Nov. 3, 2023. The listed products were not properly tested by the processor in violation of OAC 442:10-8.
OMMA issued a recall notice on June 30, 2023, involving all infused prerolls, "Space Rocks - (g)" and "Space Rocks - Sativa" produced by Graves Farm Organics, LLC (PAAA-EYKG-PCTX), from Jan. 1, 2023 to June 20, 2023. The recalled products were not properly tested.
A licensee transferred medical marijuana products to other licensees after the products failed safety testing but before notifying OMMA of the failed tests, according to the Emergency Order of Embargo and Recall.
Respondents to the Sept. 16, 2022, Emergency Order of Embargo and Recall shall use this form to request removal and disposal of subject medical marijuana products.
During routine lab inspections, OMMA discovered results that were not accurately reported by the testing lab. OMMA issued a recall notice on May 19, 2022.
An embargo is a hold on specific product(s) that were found to:
Licensed businesses cannot engage in commercial activity (sale, donation, transfer, etc.) with embargoed products without the OMMA's permission. If your business is in possession of an embargoed product, you cannot send it to a waste facility (or other commercial license). You must await further instructions from the OMMA.
A recall takes place when the OMMA has ordered for the disposal of medical marijuana or medical marijuana products that have been sold to patients or caregivers AND meet at least one of the criteria below:
The commercial licensee whose harvest or production batch is being recalled shall bear the costs for disposal of all medical marijuana waste.
After issuing the recall, dispensaries that have sold the product and the commercial licensee who grew or produced the product must assist in the recall in any way they can.
If you or your caregiver purchased a product from the above list, do not consume the product. Contact the dispensary for more information.
An embargoed product is in a holding pattern until the courts can determine whether OMMA has the authority to seize and destroy the product in question.
A recall occurs once we have confirmation that a product has been sold to patients and meets one of the below criteria:
1) exceeds allowable testing thresholds set forth under our rules;
2) is the subject of an embargo or a derivative thereof;
3) fails to meet the standards set forth in our rules.
Put another way, if a product has been embargoed, a business (including a dispensary) cannot engage in any commercial activity with that product. They can't sell it, distribute it, transport it, dispose of it, etc. They must also tag the product so it's obvious the product is under an embargo.
If a product has been recalled, the product needs to be destroyed and the businesses who have sold the product (either to patients or other businesses) are responsible for assisting with the recall in any way they can. Patients or caregivers who have purchased a recalled product need to contact the dispensary from which they bought the item to determine how they should move forward in assisting with the recall.
Patients are encouraged not to consume embargoed/recalled products.
Dispose of the product or contact the dispensary you purchased from. If a patient consumes any embargoed or recalled products and experiences an adverse health reaction, they should contact their physician immediately and fill out OMMA’s Health Impact Form.
If a business is selling a product that has been embargoed or recalled, please notify OMMA immediately via our complaint form.
